PCK Tri-Axis Dominant-Primary Series III-PR

Brassica nigra

Black Mustard

Tier IIIPCK Tri-Axis Dominant-Primary Series

Target Trait

1.95×

fold-change

Sharp-dominant tri-axis C+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01288

Genomic Edits

GC Content

45.2%

Construct Length

5,883 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPA1 + TRPM8 + CaSR

IFI Score

195

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PCK pathway operation
Cross-pathway regulatory circuit for sharp-dominant PCK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and CaSR pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PCK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier III PCK triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities